新闻与事件

object(WP_Post)#30577 (24) { ["ID"]=> int(29155) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2022-07-22 14:58:46" ["post_date_gmt"]=> string(19) "2022-07-22 13:58:46" ["post_content"]=> string(902) "The Drug Delivery to the Lungs DDL 2022 conference returns to Edinburgh, UK as an in-person event for the first time in two years. We look forward to supporting the conference as Gold sponsors. As a leading conference and industry exhibition dedicated to pulmonary drug delivery, DDL offers researchers a forum for presenting recent developments in the field of inhalation therapy through both podium and poster presentations. The three-day conference consists of a programme of lectures covering five session themes, providing attendees with a space for meeting colleagues, discussing research and networking with leading inhaler testing solution and service providers. To arrange a meeting with a member of the Copley team during DDL 2022, please contact us at sales@copleyscientific.co.uk." ["post_title"]=> string(35) "Drug Delivery to the Lungs DDL 2022" ["post_excerpt"]=> string(23) "7th - 9th December 2022" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(6) "closed" ["post_password"]=> string(0) "" ["post_name"]=> string(35) "drug-delivery-to-the-lungs-ddl-2022" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2022-07-25 09:47:11" ["post_modified_gmt"]=> string(19) "2022-07-25 08:47:11" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(63) "https://www.copleyscientific.com/?post_type=events&p=29155" ["menu_order"]=> int(0) ["post_type"]=> string(6) "events" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30600 (24) { ["ID"]=> int(29226) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2022-09-14 08:24:52" ["post_date_gmt"]=> string(19) "2022-09-14 07:24:52" ["post_content"]=> string(4783) "14 September 2022; Nottingham, UK: EnviroMate™ is a benchtop environmental control chamber from Copley, the world’s leading manufacturer and supplier of inhaler testing equipment, designed specifically to improve the repeatability and integrity of inhaler test data. The performance of orally inhaled and nasal drug products (OINDPs) can be directly influenced by ambient temperature, humidity and electrostatics found in the laboratory, as highlighted by the US and European Pharmacopoeias. EnviroMate is an accurate, efficient, low maintenance solution that addresses these issues with considerable value for scientists faced with:

• Variable lab conditions or inadequate climate control
• OINDPs with high sensitivity to temperature, humidity and/or electrostatics, such as powders and aqueous formulations where hygroscopicity and evaporation can be an issue
• Poor inter- or intra-lab reproducibility and unexplained out-of-specification (OOS) results
• Achieving better environmental control, in a cost-effective manner, without investing in a dedicated room for testing.

Delivered dose uniformity (DDU) testing and aerodynamic particle size distribution (APSD) measurement by cascade impaction are critical tasks for the inhalation community. Variability in the test environment can affect the dose emission and aerosol generation performance of OINDPs, and APSD measurement methods, compromising the integrity of these tests. By tackling this source of variability EnviroMate reduces the risk of erroneous data and costly testing delays. EnviroMate is a compact, movable, benchtop unit with a spacious, clear-view chamber, large hinged front door, and slot-sealed rubber entry ports. It comfortably accommodates the Inhaler Testing Workstation™, all types of cascade impactor (including preseparator and mixing inlet as required) with dedicated side wall ports and quick-connectors for interfacing with externally located ancillaries. EnviroMate accurately controls and maintains uniform temperature (± 2°C) and humidity (± 5% RH) by circulating air through the entire chamber, whilst an integrated anti-static system helps to minimise electrostatic effects. The unit contains a self-regenerating desiccant dehumidifier and is refrigerant-free, easing maintenance and environmental impact. “Controlling environmental conditions precisely during the testing of OINDPs is crucial, but is typically complex and expensive,” says Mark Copley, CEO, Copley Scientific. “The EnviroMate is a pragmatic, well-engineered, highly effective option tailored specifically to inhaler testing requirements. It’s a great addition to our range and we’re sure it will have a positive impact on the quality of test data, for those struggling to achieve stable conditions during DDU and APSD testing.”

The new EnviroMate™ is a cost-efficient, benchtop solution that provides stable environmental conditions for inhaler testing.

ENDS

About Copley Scientific Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(95) "Copley launches EnviroMate™, an efficient, benchtop environmental chamber for inhaler testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(26) "copley-launches-enviromate" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2022-09-14 08:27:24" ["post_modified_gmt"]=> string(19) "2022-09-14 07:27:24" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=29226" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30588 (24) { ["ID"]=> int(14167) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-06-23 08:49:35" ["post_date_gmt"]=> string(19) "2021-06-23 07:49:35" ["post_content"]=> string(4969) "23 June 2021; Nottingham, UK: Copley Scientific has joined the Industries Forum of the Taskforce for Lung Health. The Taskforce is a collaboration of over 30 members including patients, health care professionals, the voluntary sector and professional associations all working together to represent the needs of people with lung disease. The Taskforce’s Industries Forum is a group of representatives from the pharmaceutical, diagnostics, devices, and digital industries that works alongside the Taskforce to improve the diagnosis, treatment, and care of patients living with lung disease in England. Company experts will join regular meetings of the Industries Forum to share relevant industry views, intelligence, and experience. As the world’s leading manufacturer and supplier of inhaler test equipment, Copley brings unique perspective on the safety and quality issues associated with inhaler testing and use. The Taskforce has established a five-year plan to improve all aspects of lung disease management from the preservation of good lung health, through to earlier, more effective disease diagnosis, and end of life care. Working groups focusing on Early Diagnosis, Medicines Optimisation, and Pulmonary Rehabilitation, help to implement the associated recommendations of the five year plan. These groups draw on a wide range of expertise from the Taskforce and the Industries Forum to ensure optimal solutions to some of the most demanding challenges associated with lung health. Copley, a family-owned UK company currently celebrating 75 years in business, develops and manufactures equipment for in vitro inhaler testing that is used to optimise the safety and efficacy of drugs for conditions such as asthma, COPD, and cystic fibrosis. Developing solutions that make in vitro testing more clinically representative is currently an important task, and a good example of the insight that Copley has to offer. Such solutions help researchers to efficiently build an increasingly accurate and detailed understanding of how to improve inhaled drug delivery and how patient physiology and technique impact its success. This knowledge informs better device design for specific patient groups and a more robust assessment of the potential for inadequate drug delivery, where technique is compromised. “We’re looking forward to investing in the very worthwhile work of the Taskforce for Lung Health,” said Mr Mark Copley, CEO, Copley Scientific. “Lung health is currently at the forefront of people’s minds, and I hope we can help to make real progress in patient outcomes. Copley occupies a distinctive position within the inhaled product research community, and we’re pleased to be able to contribute our insight and expertise to more directly support lung disease sufferers across England.” Learn more about the work of the Taskforce, here: https://www.blf.org.uk/taskforce

CAPTION: Copley is proud to announce joining the Taskforce for Lung Health as its newest Industries Forum member.

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com" ["post_title"]=> string(77) "Copley Scientific joins the Industries Forum of the Taskforce for Lung Health" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(77) "copley-scientific-joins-the-industries-forum-of-the-taskforce-for-lung-health" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-06-23 08:49:35" ["post_modified_gmt"]=> string(19) "2021-06-23 07:49:35" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=14167" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30592 (24) { ["ID"]=> int(12746) ["post_author"]=> string(1) "2" ["post_date"]=> string(19) "2021-03-12 13:09:34" ["post_date_gmt"]=> string(19) "2021-03-12 13:09:34" ["post_content"]=> string(5372) "11 March 2021, Nottingham, UK: Copley Scientific, the global leader in OINDP testing equipment, has introduced a series of new accessories that work with established products to deliver efficient, integrated solutions for measurement of the critical quality attributes of nasal sprays, aerosols, and powders. Currently the subject of intense research activity, particularly for generics manufacturers, nasal products deliver drugs for both local and systemic action. The new range of accessories allows customers to:

• Reproducibly measure the delivered dose uniformity (DDU) of nasal sprays, in line with regulatory requirements, using automated and manual methodologies.
• Easily establish robust, automated nasal drug product test set-ups to measure the aerodynamic particle size distribution (APSD) of the respirable fraction of the dose.
• Improve in vitro-in vivo correlations (IVIVCs) and study regional droplet deposition in the nasal cavity, to optimise drug delivery via a target pathway.

DDU measurement for nasal sprays calls for firing of the product into a vertically mounted sampling apparatus. The new Nasal Spray Dose Collector (NSDC) and Nasal Spray Waste Collector (NSWC) have been designed specifically for this purpose. While useful for manual DDU testing, they can be integrated with the Vertus II/Plus automated shake and fire system in a highly productive test set-up that maximises the reproducibility of DDU measurements while alleviating the health and safety risks associated with repeated manual nasal spray product operation. The new Alberta Idealised Nasal Inlet (AINI) is an important step forward in terms of achieving more clinically representative nasal product testing and is particularly valuable for the demonstration of bioequivalence. Building on the reputation of the Alberta Idealised Throat, the AINI was originally developed by Professor Finlay from the University of Alberta and has an idealised clinically validated geometry created from Computer Tomography (CT) scans of individual subjects. It is made up of four individual regions – the vestibule, turbinate, olfactory and nasopharynx – and mimics deposition behaviour in each while simultaneously generating a sample that accurately reflects the respirable dose. Manufactured from aluminium, the AINI has a robust, leak-free, easy-to-use design. It can be used with a filter, such as the Fine Fraction Collector, to quantitatively determine drug deposition by chemical recovery and assay or interfaced with a cascade impactor to representatively measure the APSD of the respirable fraction. Further accessories additionally enable interfacing of the Vertus II/Plus with any routinely used cascade impactor, via an expansion chamber or AINI, for representative measurement of the APSD of the sub-10 microns, respirable fraction of the dose. Such testing is essential to quantify the risk of drug delivery via the lung, rather than via the nasal cavity. As with DDU testing, use of the Vertus II/Plus with cascade impactors such as the Next Generation Impactor and Andersen Cascade Impactor for this application, reduces measurement variability, boosts productivity, and alleviates health and safety concerns. Find out more about the new nasal product testing portfolio and how it can accelerate nasal product development: www.copleyscientific.com

CAPTION: The Alberta Idealised Nasal Inlet enables the generation of drug deposition data for four specific regions of the nasal passageways and interfaces with all pharmacopoeia-recommended cascade impactors

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com" ["post_title"]=> string(65) "Copley introduces a comprehensive range for nasal product testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(65) "copley-introduces-a-comprehensive-range-for-nasal-product-testing" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-06-21 11:29:48" ["post_modified_gmt"]=> string(19) "2021-06-21 10:29:48" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(41) "https://www.copleyscientific.com/?p=12746" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30597 (24) { ["ID"]=> int(11449) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2021-02-04 13:02:57" ["post_date_gmt"]=> string(19) "2021-02-04 13:02:57" ["post_content"]=> string(4195) "14 January 2021; Nottingham, UK: Copley Scientific is now delivering e-Training, offering customers across the globe remote access to expert tuition on in vitro test methods for pharmaceutical dosage forms, notably for orally inhaled and nasal drug products (OINDPs). Customers can choose from a range of standard training packages or specify a bespoke session, with reliable, professional, live-streaming ensuring a high quality, interactive experience. Sessions on Installation Qualification and Operational Qualification (IQ/OQ) help customers to get new systems up and running while application-specific training ensures best practice. “Over the years we’ve welcomed many customers to Copley HQ for training, and we know that service is highly valued,” said Anna Sipitanou, Business Development Manager for Copley. “The global pandemic has rapidly brought about new ways of working for many of us. By establishing e-Training we can now offer expert input even when traditional visits aren’t practical. Going forward e-Training will mean greater flexibility, a choice between a visit or in-house learning, to suit individual requirements.” Copley, the world’s leading manufacturer and supplier of inhaler test equipment, is particularly well-known for training in the complex area of in vitro OINDP testing. Expert advice helps customers to fully utilise the company’s comprehensive range of OINDP test equipment and enhance the clinical relevance of in vitro data. However, the e-Training offering is extensive and also available for:

• testing of multiple pharmaceutical dosage forms including oral solid dosage, semi-solids, and suppositories
• a wide range of applications and test methods
• installation qualification/operational qualification (IQ/OQ) requirements; the validation processes required to bring new equipment into routine use.

Completion is certified for all courses. “Nothing should stop people efficiently validating their new equipment or accessing the training they need to get the most out of our products,” said Anna Sipitanou. “I’m delighted to have the e-Training service established and the team is looking forward to delivering the first sessions.” Contact sales@copleyscientific.co.uk to arrange your e-Training session.

CAPTION: Copley Scientific extends their training service options to include e-Training

ENDS

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness), capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products.  www.copleyscientific.com" ["post_title"]=> string(61) "New e-Training service from Copley for pharmaceutical testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(63) "new-e-training-service-from-copley-for-pharmaceutical-testing-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-24 10:30:49" ["post_modified_gmt"]=> string(19) "2021-02-24 10:30:49" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(49) "https://www.copleyscientific.com/zh-hans/?p=11449" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30591 (24) { ["ID"]=> int(10442) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:48:27" ["post_date_gmt"]=> string(19) "2020-11-03 11:48:27" ["post_content"]=> string(3968) "20 April 2020; Nottingham, UK: Copley Scientific will shortly begin the company’s inaugural series of technical webinars, offering valuable, easy to understand overviews on key aspects of inhaler testing. Copley is the world’s leading manufacturer and supplier of inhaler test equipment and exemplary training is a hallmark of the company’s customer-centric approach. Each ‘Quick guide to…’ webinar will focus on the specific device type to be tested - metered dose inhalers (MDIs), dry powder inhalers (DPIs) or nebulisers - or a critical area of interest such as regulatory updates and achieving better in vitro-in vivo correlations (IVIVCs). The new series will run over the coming quarter, building to an important resource for both novice and experienced researchers. Register here to attend the first webinar, on MDIs, at 10:00 AM (BST) on April 29th, which will be delivered by Anna Sipitanou, Business Development Manager and one of Copley’s most knowledgeable trainers. “I’m looking forward to delivering the first in this webinar series,” said Anna Sipitanou, “since I know we’ll be able to share a lot of information that customers will find helpful. The aim is to provide an up-to-date overview in each area. Those new to inhaler testing can use this as an introduction, while those with more experience can brush up on the basics and learn about new developments. Once complete the full series will usefully complement the comprehensive, in-house and tailored training we provide to directly meet specific customer requirements.” The webinars will draw on Copley’s extensive knowledge of the regulatory requirements for both delivered dose uniformity testing and aerodynamic particle size distribution measurement and practical experience of helping laboratory analysts implement effective testing strategies. “Topics on the agenda for the initial MDI webinar include regulatory in vitro testing requirements, common issues encountered in testing and troubleshooting,” said Anna Sipitanou. “All the webinars will be around an hour long and conclude with time for questions. There’s no charge to attend so I’m hoping plenty of people will take the opportunity to advance their learning and understanding.”

CAPTION: Copley Scientific launches their inaugural webinar series for inhaler testing

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley products. www.copleyscientific.com" ["post_title"]=> string(55) "Copley launches a new webinar series on inhaler testing" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(57) "copley-launches-a-new-webinar-series-on-inhaler-testing-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:19:28" ["post_modified_gmt"]=> string(19) "2021-02-10 15:19:28" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10442" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30590 (24) { ["ID"]=> int(10438) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:48:06" ["post_date_gmt"]=> string(19) "2020-11-03 11:48:06" ["post_content"]=> string(4365) "28 November 2019; Nottingham, UK: New recruits to the Copley Scientific team are helping to bring innovative pharmaceutical test equipment to customers faster, as the company invests heavily in a product pipeline matched to industry needs. Edward Brundrett, a new technical sales executive is working to enhance every aspect of the sales process while Mark Lo brings fresh advanced mechanical engineering knowledge to the design team. “We’re committed to providing a sales team that combines the technical expertise and responsiveness needed to serve our customers effectively and we are delighted to welcome Edward to it,” said Richard Postlethwaite, Chief Operating Officer, Copley Scientific. “As global leaders in testing equipment for inhalers and other dosage forms, we routinely break new ground with innovative products for faster, more reliable and more patient representative testing. Our knowledgeable sales team supports customers in identifying which products will help them to best address the challenges they face, and we are committed to investing in its growth and evolution.” With a reputation for continuous improvement, Copley has recently added market-leading automation expertise to its portfolio with the acquisition of Novi Systems. This brings a new dimension to the design process. “Mark joins an experienced and highly successful design team at a particularly exciting time,” continues Richard Postlethwaite. “The smart use of automation has significant potential to reduce the variability associated with inhaler testing, which, due to its complexity, remains predominantly manual in most labs. And, of course, to boost productivity. A defining focus for the design team is the evolution of our extensive portfolio to allow customers to answer to increasingly complex regulatory requirements, as efficiently as possible.” Copley designs and manufactures the equipment required for testing metered-dose inhalers, dry powder inhalers, nebuliser and nasal sprays, as well as tablets, capsules, suppositories, transdermals, powders, granules, creams and ointments, from R&D through to QC. An unrivalled understanding of the practicalities of testing, in combination with a track record of collaborating closely with the industry in order to precisely define requirements, underpins the success of the current, broad product range. “It is extremely rewarding to be working on products that we know will bring real value to our customers,” said Richard Postlethwaite “and we look forward to delivering them with exemplary levels of customer service.”

CAPTION: New Technical Sales Executive, Edward Brundrett (middle) and new Design Engineer, Mark Lo (right) welcomed to the company by Chief Operating Officer, Richard Postlethwaite (left).

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulisers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products. www.copleyscientific.com" ["post_title"]=> string(140) "Delivering the next generation of pharmaceutical testing equipment: Copley Scientific welcomes new engineers into the sales and design teams" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(141) "delivering-the-next-generation-of-pharmaceutical-testing-equipment-copley-scientific-welcomes-new-engineers-into-the-sales-and-design-teams-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-22 17:20:15" ["post_modified_gmt"]=> string(19) "2021-02-22 17:20:15" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10438" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30593 (24) { ["ID"]=> int(10435) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:47:54" ["post_date_gmt"]=> string(19) "2020-11-03 11:47:54" ["post_content"]=> string(4178) "16 November 2018; Nottingham, UK: At Drug Delivery to the Lung 2018 (12 – 14th Dec, Edinburgh, UK) Copley Scientific, the global leader in inhaler testing equipment, will release ‘Quality Solutions for Inhaler Testing – 2019 Edition’, the company’s comprehensive brochure that sets products within the context of detailed, practical guidance on all aspects of testing. Substantially updated with new solutions for both novel and generic product development, the brochure is particularly helpful as the regulatory landscape for the industry undergoes significant change. It is a valuable reference resource for anyone working with orally inhaled and nasal drug products (OINDPs) including: metered-dose inhalers (MDIs), dry powder inhalers (DPIs), nebulisers and nasal sprays. Drop by the Copley stand to pick up a copy hot off the press! Products making their debut in the 2019 Edition reflect a dramatic rise in product-specific Food and Drug Administration (FDA) guidances and US pharmacopoeia monographs. Accessories for testing Albuterol Inhalation Aerosols, for example, answer directly to specifications in the recently proposed draft product-specific US Pharmacopoeia (USP) monograph. New inclusions also support industry efforts towards more clinically representative testing and enhanced reproducibility. The new Facemask Test Stand (FMS) and Next Generation Impactor to FMS Interface Accessory, for instance, make it easier to test nebulisers with a facemask in place to obtain more clinically realistic data. Enhanced IVIVC (in vitro in vivo correlation) test systems all feature. Several core Copley ancillaries have recently been upgraded to deliver enhanced reproducibility via superior automation, state-of-the-art technology and innovative design. These include the TPK™ 2100 Critical Flow Controller, a vital accessory for DPI testing, and the BAC™ 2100, an advanced Breath Actuation Controller for automating the flow control associated with testing MDIs. Incorporating robust, automated data reporting, these next-generation products make testing easier and more productive, while at the same time minimising the potential impact of user variability. On display at DDL will be a BAC™ 2100, complete with MDI Actuation Sensor, a discrete device that clips onto the MDI canister to sense manual actuation and enable automatic flow synchronisation. Visit the stand to take a closer look at how it enhances MDI testing, to view other products and/or to find out more about any aspect of inhaler testing. To see Copley’s full range of equipment for inhaled drug testing download “Quality Solutions for Inhaled Testing” from http://www.copleyscientific.com/downloads/brochures

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products." ["post_title"]=> string(99) "Copley Scientific to release new edition of ‘Quality Solutions for Inhaler Testing’ at DDL 2018" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(95) "copley-scientific-to-release-new-edition-of-quality-solutions-for-inhaler-testing-at-ddl-2018-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:31:33" ["post_modified_gmt"]=> string(19) "2021-02-10 15:31:33" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10435" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30587 (24) { ["ID"]=> int(10434) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:47:51" ["post_date_gmt"]=> string(19) "2020-11-03 11:47:51" ["post_content"]=> string(4526) "6 November 2018; Nottingham, UK: Copley Scientific is closing a year of innovation and renewal across the inhaled product testing range with two upgrades that further enhance routine analysis: a new Mixing Inlet and a firmware update for the TPK™ 2100 Critical Flow Controller. The Mixing Inlet allows application of a patient-representative inhalation profile during aerodynamic particle size distribution (APSD) measurement and is used to achieve better in vitro in vivo correlations (IVIVCs). The new, one-piece, all 316 stainless steel construction is designed to be more robust and chemically inert for the drug recovery process. The TPK™ 2100 Critical Flow Controller is a key accessory for flow rate control in dry powder inhaler testing (DPI) that now offers enhanced logging and recording capabilities as a result of the latest firmware update (Version 2.00). Find out more about both products by contacting: sales@copleyscientific.co.uk The APSD of inhaled products is a Critical Quality Attribute, measured using a cascade impactor, typically either the Andersen Cascade Impactor (ACI) or Next Generation Impactor (NGI). Cascade impactors are precision instruments that operate at a constant volumetric air flow rate. The Mixing Inlet decouples flow through the test product from that entering the impactor making it possible to apply a clinically realistic inhalation profile during measurement while meeting the constraint of constant flow, at a calibrated rate, at the inlet to the impactor. Available in both ACI and NGI versions, the new Mixing Inlet has a 316 stainless steel construction to aid drug recovery and optimise drug/solvent compatibility. A one-piece, rigid design offers enhanced induction port support and protects the sharp edge of the inner cone from damage; the avoidance of internal ‘O’ rings also eliminates a potential source of leaks. By gently mixing sample-laden air with any supplementary air required, the Mixing Inlet produces a homogeneous test flow for the impactor, while minimising internal drug losses. The key function of the TPK™ 2100 is to control the air flow entering the impactor for DPIs, ensuring stable, critical flow and a defined pressure drop across the inhaler - 4 kPa when applying compendial test methods. This pressure drop (P1) is now recorded and logged for every test providing a traceable record of compliance and correct inhaler operation. This additional functionality further boosts the utility of the TPK™ 2100; existing units can be upgraded to the latest software version for a fee. To see Copley’s full range of equipment for inhaled drug testing download “Quality Solutions for Inhaler Testing” from http://www.copleyscientific.com/downloads/brochures.

CAPTION: The new Mixing Inlet is a robust accessory for the more clinically realistic measurement of APSD by cascade impaction.

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products." ["post_title"]=> string(78) "Copley Scientific rounds off a year of range renewal with two product upgrades" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(80) "copley-scientific-rounds-off-a-year-of-range-renewal-with-two-product-upgrades-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:32:32" ["post_modified_gmt"]=> string(19) "2021-02-10 15:32:32" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10434" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30589 (24) { ["ID"]=> int(10433) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:47:49" ["post_date_gmt"]=> string(19) "2020-11-03 11:47:49" ["post_content"]=> string(4853) "30 October 2018; Nottingham, UK: A major extension that more than doubles the size of Copley Scientific’s UK headquarters, located in Colwick in the Borough of Gedling, is now officially ready for business, following a formal opening by local Member of Parliament (MP) Vernon Coaker. Mr Coaker cut a ribbon on the entrance doors to the new building before joining the Copley team for a celebratory lunch. Completed in just over 18 months – from breaking ground to official opening – the new building and refurbishment of the existing building, are a direct response to sustained growth over a number of years and make a confident statement regarding the company’s future. "I’d like to thank Mark Copley and his team for making me so welcome here today,’ said Vernon Coaker ‘and to pay tribute to the hard work, drive and commitment that has made Copley Scientific the thriving company that it is today. Copley has flourished by remaining relevant and responsive to the needs of a pharmaceutical industry that has changed beyond all recognition since the 1940s when the company was founded. From its origins as a supplier to local businesses Copley has become a global leader in its chosen field, directly supporting the development of novel drug products that have a transformative impact on the day-to-day lives of so many people." Founded by Frank Copley in 1946, Copley Scientific began as a laboratory glassware supplier to the local pharmaceutical industry, in particular, Boots the Chemist, a well-known Nottingham company. The transition to pharmaceutical test equipment – especially tablets – began in the 1950s with growing emphasis on inhaler testing from the 1980s onwards, as the science of pulmonary drug delivery developed rapidly. Today, Copley is widely acknowledged as the world’s leading manufacturer and supplier of inhaler testing equipment and a major supplier of tablet and detergent testing equipment, with product innovation, quality and value recognised across the globe. More than 85% of company’s products and services are exported to markets such as Europe, US, India and China, but most company functions, including manufacturing and assembly, remain in the UK. "Copley illustrates that with the right blend of agility, engineering excellence and customer service UK companies can compete extremely effectively in the global marketplace,’ said Mr Coaker. ‘I’m particularly impressed with the new, high-tech product development and manufacturing facility and the state-of-the-art customer training and entertainment suite. It is very clear that Copley has laid the firmest of foundations for future growth and I wish the company every success in its world-class headquarters." For more information about Copley Scientific and the products it makes please contact: sales@copleyscientific.co.uk. Alternatively, to see the full range go to http://www.copleyscientific.com/downloads/brochures

CAPTION: Vernon Coaker MP impressed by the global reach of Copley Scientific, discussing export success with distributors present at the opening.

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products." ["post_title"]=> string(68) "Local MP officially opens expanded Copley Scientific UK headquarters" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(70) "local-mp-officially-opens-expanded-copley-scientific-uk-headquarters-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:33:50" ["post_modified_gmt"]=> string(19) "2021-02-10 15:33:50" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10433" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30564 (24) { ["ID"]=> int(10432) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:47:46" ["post_date_gmt"]=> string(19) "2020-11-03 11:47:46" ["post_content"]=> string(4436) "29 August 2018; Nottingham, UK: An engaging autumn conference schedule provides customers with valuable opportunities to access expert advice from the Copley Scientific global team, as well as to see the company’s latest products. China is a primary geographical focus with two key events on the horizon. At a joint AAPSCDG/NIFDC/IPAC-RS workshop focusing on Inhalation Preparations and Novel Drug Delivery in Beijing, Sept 13th – 14th, Mr Mark Copley, CEO, Copley Scientific, will present on the topic of ‘Improving the Clinical Relevance of In-vitro Testing Methods for Orally Inhaled Products.’ Greater clinical relevance enhances the value of in vitro testing in product development and in the demonstration of bioequivalence and is an important goal for the industry. Mr Copley will discuss how test set-ups can be refined to boost clinical realism without introducing excessive complexity. Nebulisers will be the focus at the Inhalation Drug Delivery Association (IDDA) Conference 2018, Oct 19th – 21st, Nanjing, where Copley is sponsoring a workshop which will be led by Dr Anny Shen, a leading expert in inhaled drug delivery and Copley’s representative in China. Nebulisers are widely used in China and testing is complicated by the need to simulate the tidal breathing pattern applied by the patient during product use. Breathing simulators are vital for delivered dose uniformity (DDU) testing and are also now increasingly deployed to gather more representative aerodynamic particle size distribution (APSD) data. Dr Shen will be demonstrating optimized and efficient test set-ups for all requirements. Lastly, Mr Mark Copley will join other invited experts from across the inhalation community at the annual Management Forum conference on Inhaled Drug Delivery which takes place in London, on Nov 1st and 2nd. In a wide-ranging presentation he will provide an introduction to different inhaler device types - highlighting how design and method of use impact testing - review current regulatory requirements and discuss techniquesfor DDU testing and APSD measurement. The talk will conclude with insights on the latest advances in in vitro test methods, to improve bioequivalence testing and to achieve better in vitro in vivo correlations (IVIVCs). To find out more about events taking place in China contact: sales@copleyscientific.co.uk To find out more about, or to register for, the Management Forum conference go to https://management-forum.co.uk/product/details/1714/inhaled-drug-delivery/c22

CAPTION: Copley Scientific is beginning a busy autumn conference schedule that provides multiple opportunities for expert engagement.

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products." ["post_title"]=> string(69) "Copley Scientific offers valuable opportunities for expert engagement" ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(71) "copley-scientific-offers-valuable-opportunities-for-expert-engagement-2" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:34:37" ["post_modified_gmt"]=> string(19) "2021-02-10 15:34:37" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10432" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }

object(WP_Post)#30584 (24) { ["ID"]=> int(10431) ["post_author"]=> string(1) "1" ["post_date"]=> string(19) "2020-11-03 11:47:43" ["post_date_gmt"]=> string(19) "2020-11-03 11:47:43" ["post_content"]=> string(4320) "26 July 2018; Nottingham, UK: Hands-on demonstrations at Copley Scientific’s UK headquarters are proving the perfect introduction to the upgraded NGI (Next Generation Impactor) Assistant, a labour-saving device that boosts the precision and productivity of inhaler testing to unprecedented levels. Cascade impaction is used to determine the aerodynamic particle size distribution (APSD) of all orally inhaled products; a critical quality attribute. The NGI Assistant automates the associated drug recovery process, making the conversion of NGI samples to solutions for HPLC analysis a simple, reproducible ‘load and go’ operation. The latest model offers shorter cycle times – boosting throughput and return on investment – and a simplified, easy-to-use interface. It frees analysts up for higher-value work while at the same time improving data integrity by eliminating costly errors and operator-to-operator variability. To see the benefits first-hand contact: sales@copleyscientific.co.uk Cascade impactors produce a series of size-fractionated samples which are recovered and analysed to generate an APSD specifically for the active ingredient(s) within an inhaled formulation. The NGI Assistant holds up to three complete NGI cup trays, but can also accommodate induction ports and preseparators, as required. Solvent is automatically dispensed by a robust, low maintenance liquid handling system to a volumetric accuracy of ~±1%. The proven gentle rocking platform ensures complete dissolution of the drug and aliquots of the resulting solutions are then aspirated into standard HPLC vials for direct analysis. The new system can accommodate dual HPLC vial racks, offering the capability to collect both primary and back-up samples for each NGI test undertaken. It is compatible with a wide range of solvents and specified with vials for industry-standard HPLC systems (Waters and/or Agilent); customisation for alternative vials is also available on request. Substantially upgraded Windows-based software provides an intuitive interface, making it easier to customise methods and safeguard data integrity via a range of security and electronic records management features. In combination, the hardware and software provide an efficient, highly reproducible, turn-key solution for automated drug recovery that can be used with confidence by multiple operators, throughout the lab. To find out more contact: sales@copleyscientific.co.uk

CAPTION: The new NGI Assistant makes light work of the drug recovery process associated with cascade impaction, boosting the precision and productivity of inhaler testing

About Copley Scientific

Copley Scientific is widely recognised as the world’s leading manufacturer and supplier of inhaler test equipment and is a major provider of testing systems for other pharmaceutical dosage forms. The company also supplies equipment for detergent testing. Copley Scientific’s pharmaceutical product range includes test equipment for all types of orally inhaled and nasal drug products - metered-dose inhalers, dry powder inhalers, nebulizers and nasal sprays - with a particular focus on solutions for delivered dose uniformity and aerodynamic particle size distribution measurement. It also includes testers for tablets (dissolution, disintegration, friability and hardness) capsules, powders, suppositories, semisolids and transdermals. Used from R&D through to QC, this extensive range of equipment is supported by a full validation and aftersales service. Copley Scientific has offices in the UK and Switzerland and works in partnership with aerosol particle science experts MSP Corporation in North America; specialist distributors extend localised support across the world. This network provides expert help and training to every customer, directly enhancing the application of all Copley Scientific products." ["post_title"]=> string(98) "Introducing the new NGI Assistant, a labour-saving device for higher productivity inhaler testing." ["post_excerpt"]=> string(0) "" ["post_status"]=> string(7) "publish" ["comment_status"]=> string(6) "closed" ["ping_status"]=> string(4) "open" ["post_password"]=> string(0) "" ["post_name"]=> string(96) "introducing-the-new-ngi-assistant-a-labour-saving-device-for-higher-productivity-inhaler-testing" ["to_ping"]=> string(0) "" ["pinged"]=> string(0) "" ["post_modified"]=> string(19) "2021-02-10 15:35:24" ["post_modified_gmt"]=> string(19) "2021-02-10 15:35:24" ["post_content_filtered"]=> string(0) "" ["post_parent"]=> int(0) ["guid"]=> string(35) "https://copley.fifteen.dev/?p=10431" ["menu_order"]=> int(0) ["post_type"]=> string(4) "post" ["post_mime_type"]=> string(0) "" ["comment_count"]=> string(1) "0" ["filter"]=> string(3) "raw" }